Navigation Links
Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
Date:5/15/2012

d a variable risk of transformation to acute myeloid leukemia.  It is estimated that MDS affects approximately 300,000 people worldwide.  According to the American Cancer Society, 10,000–20,000 new cases of MDS are diagnosed each year in the United States, with survival rates ranging from six months to six years.  MDS patients often require multiple blood transfusions to manage their disease.

Telintra has a novel mechanism of action that inhibits an enzyme called glutathione S-transferase P1-1, which leads to activation of Jun kinase, a key regulator of cellular growth and differentiation of blood precursor cells; this mechanism induces cancer cell death, or apoptosis, in human leukemia cell lines. Telintra is also being evaluated in a Phase 2 clinical trial in Revlimid refractory and resistant deletion 5q MDS patients and a Phase 2b clinical trial in non-deletion 5q MDS patients.  Additional information about Telintra is available at www.telik.com.

About Telik, Inc.

Telik, Inc. of Palo Alto, CA, is a clinical-stage drug development company focused on discovering and developing small-molecule drugs to treat cancer.  The company's most advanced drug candidate is Telintra, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome, followed by Telcyta®, a cancer-activated prodrug for the treatment of a variety of cancers.  Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small-molecule drug candidates.

This press release contains "forward-looking" statements regarding the future development of Telintra, the safety and effectiveness of Telintra in treating MDS, whether Telintra treatment results in hematologic improvement in patients with MDS, whether Telintra reduces the need for, or offer
'/>"/>

SOURCE Telik, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Telik Regains Compliance With Minimum Bid Price Requirement
2. Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance
3. Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference
4. Telik Announces Telintra Clinical Presentations at the Annual Meeting of the American Society of Hematology
5. Telik Announces Third Quarter 2011 Financial Results
6. Telik Announces Publication of a Report of Complete Response of G-CSF Resistent Severe Idiopathic Chronic Neutropenia Following Treatment with Telintra®
7. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients With Low to Intermediate-1 Risk Non-Deletion (5q) Myelodysplastic Syndrome
9. Telik Announces Publication in the Journal Cancer of a Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome
10. Telik Announces First Quarter 2011 Financial Results
11. Telik Announces Presentation of New Data on the Characterization of Novel Ezatiostat (TELINTRA®, TLK199) Analogs at American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... and REHOVOT, Israel, Sept. 3, 2015 OticPharma, ... developing innovative therapies for ear, nose, and throat (ENT) ... Newport Gateway office complex to be the location of ... move by end of September and will have office ... Headquarters: OticPharma, Inc. 19900 MacArthur Blvd., Suite ...
(Date:9/2/2015)... YORK , Sept. 2, 2015  The report ... future market of breast cancer drugs on the basis ... cancer usually originates from the inner lining of milk ... is a malignant type of tumor that can spread ... of cancer which starts in lobules is referred as ...
(Date:9/2/2015)... Sept. 2, 2015 Advanced Wound Dressings ... Advanced dressings have steadily replaced traditional bandages ... variety of wound indications, such as trauma wounds, ... control, and physical protection become increasingly critical in ... in standard therapy. This report focuses on ...
Breaking Medicine Technology:OticPharma Establishes U.S. Headquarters in Orange County, California 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2
(Date:9/3/2015)... Durham, NC (PRWEB) , ... September 03, 2015 ... ... , August 31, 2015: DiabetesSisters is pleased to announce the additional of Carol ... August 2015 by current board members Diana Karczmarczyk, Donna Rice, David Warren, Matt ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... data collection, cloud analytics and workflow solutions today announced the complete faculty ... September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry experts ...
(Date:9/3/2015)... OR (PRWEB) , ... September 03, 2015 , ... ... finest responsibility concierges; simplifying responsibilities which can impact the delicate life balance between ... socio-economic situation might be.” - Jeffrey R. Leaptrott, CEO , A LifeMinder Plus® ...
(Date:9/3/2015)... ... September 03, 2015 , ... AvePoint, the established leader ... Service Pack (SP) 4 – AvePoint’s solution for facilitating two-way collaboration and external ... 2015 Trend-Setting Product”. This is the fifth consecutive year an AvePoint product has ...
(Date:9/3/2015)... ... 2015 , ... Mum n Me is pleased to announce the launch of ... that gives maximum protection from sun exposure, wind, bugs, and germs. The Mum n ... assurance by keeping the cover securely in place. The new car seat cover is ...
Breaking Medicine News(10 mins):Health News:Carol H. Wysham, MD, Joins DiabetesSisters Board of Directors 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 2Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 3Health News:AvePoint Perimeter Named a “KMWorld 2015 Trend-Setting Product” 4Health News:Mum n Me Announces New Baby Car Seat Cover 2
... with severe problems in injection sites get benefited from ... of insulin) //– said The National Institute for Health ... suggestion has already said by the National Institute for ... not money worthy. ,But now the ...
... diabetics battle their illness with daily doses of ... diabetes, transplants of the pancreatic tissue// could help ... like blindness, amputation, kidney failure, and heart disease. ... organ donors available for transplantation. Insulin-producing pancreas tissues ...
... All India Institute of Medical Sciences (AIIMS) are helping the ... involving Rahul Mahajan. // ,The police have obtained ... Party (BJP) leader Pramod Mahajan, and managed to substantiate the ... the case, a senior official said. ,"Senior doctors ...
... medical company Biacore to complement its own healthcare division ... ,The Fairfield, Connecticut-based GE will purchase Biacore, which ... Swedish kroner ($438 million). , ,Pharmaceutical company ... Uppsala, Sweden-based Biacore, supports the bid, according to GE. ...
... wave therapy would cure ailments caused by irregular heartbeats, ... Electrophysiology said here today. // ,Speaking on ... Lifeline Hospital of the Dr K M Cherian Heart ... by irregular heartbeats, was prevalent among 10 per cent ...
... has revealed that the place of birth determines the life expectancy ... expectancy than those born in south east England //. ... to be 69.3 it was found to be 77 in East ... and it has ranked the 10 best and worst areas to ...
Cached Medicine News:Health News:Transplanted Pancreatic Tissue Could Help Diabetics 2Health News:AIIMS Doctors Assists Police in Rahul Mahajan’s Drug Abuse Cas 2Health News:Life Expectancy Determined by Place of Birth 2
... The combination of these recommendations with the ... Sorin Group has resulted in numerous improvements, ... poles and reservoir holder for hassle-free storage ... cart with just a flick of the ...
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
... Diagnostics is a clinical reference ... treatment and monitoring of hemostatic ... a collaboration of four laboratory ... defined vision to deliver customizable ...
All-natural porcine collagen can be used in open or laparoscopic placement....
Medicine Products: